Diagnosis & Disease Information

Investigational Drug Helps men with Advanced PCa

An investigational agent called abiraterone acetate significantly improves overall survival among men with advanced metastatic prostate cancer (PCa), according to new study findings presented at the 35th Annual European Society for Medical Oncology Congress.

Next post in News